Showing results (21-30 of 143) with videos related to
Sort By:
Pageof 15
Journal of the American Podiatric Medical Association|April 1, 1997
PMMA bead versus parenteral treatment of Staphylococcus aureus osteomyelitisG S Heard, L M Oloff, D A Wolfe, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial designDaniela Bertens, Betty M Tijms, Lisa Vermunt, et al.Alzheimer'S Research & Therapy|May 28, 2021
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's diseaseNiels D Prins, John E Harrison, Hui-May Chu, et al.BMC Medical Imaging|October 19, 2011
Estimating radiation effective doses from whole body computed tomography scans based on U.S. soldier patient height and weightRobert D Prins, Raymond H Thornton, C Ross Schmidtlein, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2012
Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinomaM J D Prins, R J J Verhage, F J W ten Kate, et al.Journal of Neural Transmission. Supplementum|November 29, 2002
Frequency of white matter lesions and silent lacunar infarctsE J van Dijk, N D Prins, S E Vermeer, et al.The New England Journal of Medicine|March 28, 2003
Silent brain infarcts and the risk of dementia and cognitive declineSarah E Vermeer, Niels D Prins, Tom den Heijer, et al.The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy BodiesN D Prins, W de Haan, A Gardner, et al.Journal of Clinical Pathology|September 18, 2013
Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray studyM J D Prins, J P Ruurda, P J van Diest, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2013
The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization studyM J D Prins, J P Ruurda, P J van Diest, et al.Pageof 15